Pharma Exclusives Pressreleases
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
Tuesday, December 02, 2025Roche announced today that its first pointofcare test for the diagnosis of whooping cough pertussis and other Bordetella infections has been granted US Food and Drug Administration FDA k
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Friday, November 07, 2025Today it was announced that Novo Nordisk has agreed with the US Administration to lower drug prices beginning in and expand patient access and affordability for semaglutide medicines including Wegovy
Touchlight Expands mbDNA™ Portfolio with New Circular DNA Architectures for Advanced Therapies
Thursday, November 06, 2025Touchlight a leader in cellfree DNA technology today announced the expansion of its groundbreaking mbDNA platform with the introduction of three new circular DNA architectures sscDNA hsscDNA and dscDNA
ABER Instruments and Sartorius Stedim Biotech Unveil BioPAT® Viamass Single-Use Biomass Sensors for Ambr® 250 High Throughput Bioreactors
Tuesday, November 04, 2025Aber Instruments and Sartorius Stedim Biotech today announced the introduction of the BioPATViamass singleuse biomass sensor now fully integrated into Ambr High Throughput singleuse bioreactor vessels
Novo Nordisk submits proposal to acquire Metsera, Inc.
Thursday, October 30, 2025Novo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera Inc MetseraNovo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera Inc Metsera
EMA Grants PRIME Designation to MimeTech S.r.l. for Investigational Drug Udonitrectag Lysine in the Treatment of Diabetic Foot Ulcers (DFU)
Wednesday, October 29, 2025MimeTech Srl today announced that the European Medicines Agency EMA has granted PRIority MEdicines PRIME designation to its investigational drug Udonitrectag lysine for the treatment of diabetic foot ulcers DFU
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
Tuesday, October 28, 2025Kyowa Kirin Co Ltd and Orchard Therapeutics announced that Japans Ministry of Health Labor and Welfare MHLW has granted Orphan Regenerative Medicine Product Designation to OTL also known
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
Tuesday, October 28, 2025Roche announced today statistically significant and clinically meaningful results from the phase III INShore study of GazyvaGazyvaro obinutuzumab in children and young adults aged years with idiopathic nephrotic syndrome INS The study met its prima...
Lundbeck and OpenAI join forces to unlock innovation and boost productivity
Monday, October 27, 2025H Lundbeck AS Lundbeck today announced a strategic collaboration with OpenAI to transform how the company innovates and operates across its entire value chain from molecule to patient Through the deployment of ChatGPT Enterprise
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
Wednesday, October 15, 2025Quotient Sciences a leading global drug development research and manufacturing accelerator and Biorasi a global clinical research organization CRO today announced a strategic partnership to deliver fully integrated early phase clinical trial solution...
